TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,302,022 | -65.4% | 1,112,682 | +2.9% | 0.00% | -62.5% |
| Q2 2023 | $26,847,320 | +70.7% | 1,080,810 | +3.4% | 0.01% | +60.0% |
| Q1 2023 | $15,728,110 | +30.6% | 1,045,752 | +2.7% | 0.01% | +25.0% |
| Q4 2022 | $12,046,572 | +105.4% | 1,018,307 | +2.8% | 0.00% | +100.0% |
| Q3 2022 | $5,866,000 | +46.5% | 990,858 | +5.2% | 0.00% | +100.0% |
| Q2 2022 | $4,003,000 | -55.9% | 941,672 | -1.4% | 0.00% | -66.7% |
| Q1 2022 | $9,087,000 | -49.0% | 955,423 | +1.8% | 0.00% | -40.0% |
| Q4 2021 | $17,830,000 | -41.4% | 938,394 | +2.6% | 0.01% | -50.0% |
| Q3 2021 | $30,434,000 | -9.7% | 914,467 | +5.3% | 0.01% | -9.1% |
| Q2 2021 | $33,693,000 | -16.9% | 868,582 | +3.3% | 0.01% | -26.7% |
| Q1 2021 | $40,535,000 | +7.2% | 840,963 | +15.6% | 0.02% | 0.0% |
| Q4 2020 | $37,828,000 | +104.0% | 727,169 | +4.9% | 0.02% | +66.7% |
| Q3 2020 | $18,547,000 | +46.8% | 693,053 | +6.8% | 0.01% | +50.0% |
| Q2 2020 | $12,636,000 | +132.6% | 648,658 | +17.5% | 0.01% | +100.0% |
| Q1 2020 | $5,432,000 | -4.6% | 551,936 | +7.6% | 0.00% | 0.0% |
| Q4 2019 | $5,695,000 | +116.9% | 513,048 | +9.7% | 0.00% | +50.0% |
| Q3 2019 | $2,626,000 | -30.5% | 467,649 | +7.2% | 0.00% | 0.0% |
| Q2 2019 | $3,776,000 | +20.8% | 436,433 | +12.2% | 0.00% | 0.0% |
| Q1 2019 | $3,127,000 | +119.0% | 388,848 | +11.7% | 0.00% | +100.0% |
| Q4 2018 | $1,428,000 | -22.7% | 348,214 | +5.6% | 0.00% | 0.0% |
| Q3 2018 | $1,847,000 | -55.2% | 329,647 | +5.1% | 0.00% | -66.7% |
| Q2 2018 | $4,126,000 | +8.3% | 313,752 | +17.0% | 0.00% | 0.0% |
| Q1 2018 | $3,809,000 | +73.9% | 268,174 | +0.5% | 0.00% | +50.0% |
| Q4 2017 | $2,190,000 | -24.1% | 266,970 | +9.6% | 0.00% | -33.3% |
| Q3 2017 | $2,886,000 | +226.5% | 243,485 | +176.8% | 0.00% | +200.0% |
| Q2 2017 | $884,000 | +5.2% | 87,950 | +22.1% | 0.00% | 0.0% |
| Q1 2017 | $840,000 | +83.8% | 72,050 | -26.7% | 0.00% | 0.0% |
| Q4 2016 | $457,000 | -0.2% | 98,250 | +66.4% | 0.00% | 0.0% |
| Q3 2016 | $458,000 | +27.9% | 59,050 | 0.0% | 0.00% | – |
| Q2 2016 | $358,000 | -29.0% | 59,050 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $504,000 | -28.5% | 59,050 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $705,000 | +18.3% | 59,050 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $596,000 | -27.8% | 59,050 | +18.7% | 0.00% | 0.0% |
| Q2 2015 | $826,000 | +29.7% | 49,750 | +21.0% | 0.00% | 0.0% |
| Q1 2015 | $637,000 | +16.9% | 41,100 | +19.5% | 0.00% | 0.0% |
| Q4 2014 | $545,000 | +48.1% | 34,400 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $368,000 | +13.6% | 34,400 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $324,000 | -5.8% | 34,400 | -30.9% | 0.00% | 0.0% |
| Q1 2014 | $344,000 | +76.4% | 49,800 | 0.0% | 0.00% | – |
| Q4 2013 | $195,000 | +107.4% | 49,800 | +173.6% | 0.00% | – |
| Q3 2013 | $94,000 | -22.3% | 18,200 | 0.0% | 0.00% | – |
| Q2 2013 | $121,000 | – | 18,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |